Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.
Inter Milan are hell-bent on getting revenge for their Supercoppa Italiana humiliation in Sunday’s Serie A derby clash with AC Milan.This according to today’s print edition of Milan-based ...
Some results have been hidden because they may be inaccessible to you